The Promise of Indigenous Epigenetics
By Emma Kowal,
Discover Society
| 10. 04. 2016
For the last two decades, Indigenous peoples have consistently resisted genetics on local, national and international scales. Awareness of genetics as a potentially harmful science spread through Indigenous organisations in the mid 1990s after the U.S. National Institutes of Health attempted to patent a virus found in the blood of a Papua New Guinean man, and the Human Genome Diversity Project attempted to collect DNA samples from indigenous peoples, who they called ‘Isolates of Historical Interest’, from around the world (Reardon 2005). The U.S.-based NGO Indigenous Peoples Council on Biocolonialism was formed in response.
Although genetics has transformed in the ‘post-genomic’ age (a term used for the period after the human genome was sequenced), its reputation among Indigenous peoples continues to be strained. Genetics is often seen as deterministic and victim-blaming, diverting attention and resources from social and political causes of ill-health, reinforcing ideologies of Indigenous inferiority within Western science, facilitating the theft of genetic biological resources and knowledge, and as the source of inflated, unjustified hype that offers little or no benefit to Indigenous people (TallBear 2013).
Adding the...
Related Articles
By Emma Cieslik, Ms. Magazine | 11.20.2025
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...